{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:19:13Z","timestamp":1768313953615,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ygyno.2016.04.027","type":"journal-article","created":{"date-parts":[[2016,5,8]],"date-time":"2016-05-08T18:40:55Z","timestamp":1462732855000},"page":"120-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Comparison of cytology, HPV DNA testing and HPV 16\/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5357-4708","authenticated-orcid":false,"given":"Kimon","family":"Chatzistamatiou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Moysiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoria","family":"Moschaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Panteleris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Agorastos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2016.04.027_bb0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2013part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0010","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2016.04.027_bb0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/aje\/kwu159","article-title":"An updated natural history model of cervical cancer: derivation of model parameters","volume":"180","author":"Campos","year":"2014","journal-title":"Am. J. Epidemiol."},{"issue":"Suppl. 5","key":"10.1016\/j.ygyno.2016.04.027_bb0020","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","article-title":"A review of clinical trials of human papillomavirus prophylactic vaccines","volume":"30","author":"Schiller","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2016.04.027_bb0025","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119755","article-title":"Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology","volume":"10","author":"Agorastos","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2016.04.027_bb0035","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda system: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2016.04.027_bb0040","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/AOG.0b013e318254f90c","article-title":"2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy","volume":"120","author":"Bornstein","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0045","first-page":"131","article-title":"A modified terminology for cervical intraepithelial neoplasia","volume":"75","author":"Richart","year":"1990","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0050","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/pon.2097","article-title":"Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the trial of management of borderline and other low-grade abnormal smears (TOMBOLA)","volume":"22","author":"Sharp","year":"2013","journal-title":"Psychooncology"},{"key":"10.1016\/j.ygyno.2016.04.027_bb0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/1471-0528.13462","article-title":"Adverse psychological outcomes following colposcopy and related procedures: a systematic review","volume":"123","author":"O'Connor","year":"2016","journal-title":"BJOG"},{"issue":"184","key":"10.1016\/j.ygyno.2016.04.027_bb0060","article-title":"Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study","volume":"208","author":"Cox","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jnci\/djn065","article-title":"Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test","volume":"100","author":"Ronco","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0070","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ijc.26056","article-title":"Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening","volume":"130","author":"Rijkaart","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.04.027_bb0075","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1158\/1055-9965.EPI-10-0818","article-title":"BD-ProExC as adjunct molecular marker for improved detection of CIN2+ after HPV primary screening","volume":"20","author":"Depuydt","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0080","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.04.027_bb0085","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/CEJ.0000000000000060","article-title":"Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study","volume":"23","author":"Agorastos","year":"2014","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0090","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0095","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2016.04.027_bb0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(09)70156-1","article-title":"HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial","volume":"10","author":"Kitchener","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0115","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2013.11.001","article-title":"How distressing is referral to colposcopy in cervical cancer screening?: a prospective quality of life study","volume":"132","author":"Korfage","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1600-0412.2011.01092.x","article-title":"Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study","volume":"90","author":"Kwan","year":"2011","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/oxfordjournals.jncimonographs.a003489","article-title":"Chapter 14: role of triage testing in cervical cancer screening","author":"Solomon","year":"2003","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0135","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0140","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2015.09.631","article-title":"Budget impact analysis of high-risk Hpv Dna (Hrhpv) test with 16\/18 genotyping as a primary screening method for cervical cancer in Greece","volume":"18","author":"Skroumpelos","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.ygyno.2016.04.027_bb0155","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0160","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cncy.21544","article-title":"Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices","volume":"123","author":"Blatt","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0165","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2016.04.027_bb0170","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/AOG.0000000000000669","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance","volume":"125","author":"Huh","year":"2015","journal-title":"Obstet. Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816301597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816301597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T08:20:37Z","timestamp":1718526037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816301597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0090825816301597"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.04.027","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of cytology, HPV DNA testing and HPV 16\/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}